COVID-19-associated thyroid diseases: Difference between revisions

Jump to navigation Jump to search
Line 49: Line 49:


===Laboratory Findings===
===Laboratory Findings===
===Electrocardiogram===
* There are no [[The electrocardiogram|ECG]] findings associated with [[COVID-19|COVID-1]]9-associated [[thyroid disease]].
* However, the following findings may be seen on [[The electrocardiogram|ECG]] in patients with [[thyrotoxicosis]]:
**[[Tachycardia]], ...


===X-ray===
===X-ray===

Revision as of 14:49, 14 July 2022

Template:COVID-19 thyroid disorders

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

COVID-19 has been found to affect several organs and body systems, including the endocrine system, with short-term and possible long-term consequences.

Historical Perspective

Classification

There is no established system for the classification of COVID-19-associated thyroid disorders.

Pathophysiology

The exact pathogenesis of COVID-19-associated thyroid diseases is not fully understood. However, the following hypotheses have been suggested for the development of thyroid dysfunction in COVID-19 patients.

  • Angiotensin-converting enzyme 2 (ACE2) receptors are essentially involved in SARS-CoV-2 internalization into host cells. the thyroid gland is amongst the organs which have the highest levels of ACE2 expression and activity. Therefore, following SARS-CoV-2 infection, thyroid damage could result from either a direct or immune-mediated injury.
  • COVID-19 may also cause an immune system imbalance and in severe cases a cytokine storm, which may break immunotolerance in susceptible patients, leading to new onset of immune-mediated thyroiditis, exacerbating a previous thyroid disease, or inducing a recurrence of thyroid disease.

Causes

Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus called SARS-CoV-2 is the cause of COVID-19-associated thyroid diseases.

Differentiating ((Page name)) from other Diseases

Epidemiology and Demographics

Risk Factors

There are no established risk factors for COVID-19-associated thyroid diseases.

Screening

There is insufficient evidence to recommend routine screening for COVID-19-associated thyroid diseases.

Natural History, Complications, and Prognosis

A number of observational studies have shown that COVID-19 infection may be linked to some thyroid diseases, including:

Diagnosis

Diagnostic Study of Choice

The diagnosis of COVID-19-associated thyroid diseases is made based on the thyroid function test (TFT), which measures serum levels of triiodothyronine (T3), thyroxine (T4), and thyroid stimulating hormone (TSH).

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

There are no x-ray findings associated with COVID-19-associated thyroid diseases.

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

References